Delivery Order SPE2DB22D1106-SPE2DB25FEPA0
Award Date 5/19/25
Potential Completion Date 5/20/25
Potential Value $3.3K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $1,366.76 to AmerisourceBergen Drug Corp for the supply of Glycopyrrolate 4 mg/20 ml vials. This firm fixed-price, non-set-aside contract was awarded on December 10, 2025, with an ultimate completion date of December 11, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued under...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Glycopyrrolate 0.2 mg/ml vials, a medication used in various medical treatments. The delivery order has a ceiling value of $11,409.71 and a completion date of January 17, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a delivery order (contract) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,341.26, is for the supply of glycopyrrolate 0.2 mg/ml vials (20 ml) to support military healthcare programs. The contract has a firm fixed price and an ultimate completion date of May 2, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of glycopyrrolate 0.2 mg/ml vial, 2 ml, a medication used to treat certain medical conditions. The contract has a ceiling value of $4,591.37 and a completion date of July 22, 2024. This is a firm fixed-price delivery order contract, with no set-aside designation. AmerisourceBergen holds a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Glycopyrrolate 4 mg/20 mL vials, with a ceiling value of $1,524.04. This non-set-aside, competitively awarded contract was executed on December 18, 2025, with an ultimate completion date of December 19, 2025, and operates under firm fixed-price terms. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,025.07 delivery order is for the supply of 4 mg/20 ml vials of the drug glycopyrrolate, a medication used to treat various conditions. The contract is a Firm Fixed Price Delivery Order with a completion date of September 11, 2024. Amerisourcebergen, through its Corporate Office division, will provide these pharmaceutical products to support...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a $2,706.37 delivery order for Glycopyrrolate 1 mg/5 ml vials on September 2, 2025, with an ultimate completion date of September 3, 2025. This non-set-aside, firm fixed-price contract represents a pharmaceutical supply delivery to support federal medical procurement needs. The award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of 4565616879 - GLYCOPYRROLATE 0.2 MG/ML VIAL 5ML. The contract has an ultimate completion date of August 29, 2024 and a ceiling value of $15,536.46. The contract is not set aside. AmerisourceBergen Drug Corp is a major pharmaceutical distributor that has been awarded numerous federal contracts to provide a wide range of medical commodities, including specialty...
- The U.S. government has awarded a firm fixed-price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, for the supply of GLYCOPYRROLATE INJECT medication. The contract, valued at $7,907.16, has an ultimate completion date of July 7, 2023 and was awarded on July 6, 2023 by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency. This delivery order falls under a larger indefinite delivery contract (IDC) awarded solely to...
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a $1,047.22 firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of GLYCOPYRROLATE INJECT, a medication, with a completion date of September 20, 2024. This delivery order is placed under a larger Indefinite Delivery Contract valued up to $999,999,999 held by Amerisourcebergen with the DLA Troop Support Medical, which provides a wide range of...